120 (OR = 3.3, CI = 1.14-9.7), Cross Clamp time>80 min (OR = 4.16, CI = 1.73-9.98) and IABP insertion postoperatively (OR = 19.19, CI = 3.16-116.47). The incremental risk factors for the development of complications were: Poor EF (OR = 3.16, CI = 0.87-11.52), Euroscore >7 (OR = 2.99, CI = 1.14-7.88), history of PVD (OR = 4.99, CI = 1.32-18.86). The 5 years survival was 79.2% for the CABG population and 71.5% for the valve group. (Hazard ratio = 1.78, CI = 0.92-3.46). Conclusions IABP represents a safe option of supporting the failing heart. The need for IABP especially in a high risk Valve population is associated with early unfavourable outcome, however the positive mid term results further justify its use."/>
General characteristics | |
---|---|
Number of patients | 136 |
Male/female | 99/37 |
Age (y/s) | 66.3 ± 9.9 |
Height (cm) | 171 ± 8 |
Weight (kg) | 79 ± 10 |
BSA | 1.77 ± 9.3 |
Hypertension | 42 pts |
Diabetes mellitus | 24 pts |
Euroscore | 8.43 ± 4.5 |
Significant Left main CAD | 17 pts |
Ischemic mitral regurgitation 2+/4+ | 12 pts |
Ejection fraction < 30% | 49 pts |
Operation's-time (min) | 365 ± 52 |
Cardiopulmonary bypass-time (min): | |
CABG | 102.1 ± 34.72 |
AVR & CABG | 161.5 ± 38.2 |
Complex Cases | 205 ± 38 |
Myocardial ischemia-time (min) | 89 ± 23 |
Post op Cardiac Index (L/min/m2) | 2.4 ± 1.7 |